AMENDMENT TO ASSET PURCHASE AGREEMENTAsset Purchase Agreement • April 24th, 2023 • Lucira Health, Inc. • In vitro & in vivo diagnostic substances • Delaware
Contract Type FiledApril 24th, 2023 Company Industry JurisdictionThis AMENDMENT TO ASSET PURCHASE AGREEMENT (this “Amendment”) is made and entered into as of April 18, 2023, by and between Pfizer Inc., a Delaware corporation (“Buyer”), and Lucira Health, Inc., a Delaware corporation (“Seller”).